Innosuisse Grant for AI-Assisted Second Opinions
The Swiss Innovation Agency Innosuisse is supporting PARSOR — a pipeline designed to automate and accelerate subspecialist radiology second-opinion reports, delivered worldwide within 24 hours.
RadiologyCheck GmbH is proud to announce that Innosuisse — the Swiss Innovation Agency — has approved funding for the preliminary study of PARSOR: Pipeline Automation for Radiology's Second-Opinion Reports, with the goal of making subspecialist second-opinion reports available worldwide within 24 hours.
This grant represents a significant endorsement from the Swiss Confederation's national innovation agency — confirming both the clinical relevance and the technical ambition of what RadiologyCheck is building.
What is PARSOR?
PARSOR is a research and development initiative aimed at building an automated pipeline around the non-medical, non-radiological steps of subspecialist second-opinion reporting — such as case intake, image and data handling, structuring, and formatting. The diagnostic finding itself is always created and signed by the board-certified subspecialist radiologist; the AI model never generates or authors the finding. The goal: structured, board-certified subspecialist reports — in any language, for any patient, anywhere in the world — within 24 hours.
Why this matters?
Radiology is at a turning point. The number of MRI and CT scans performed globally grows every year — but the number of qualified subspecialists does not grow at the same pace. PARSOR addresses this directly: not by replacing human expertise, but by taking the non-medical workload off the subspecialist's desk, so that board-certified subspecialists can spend their time on what only they can do — interpreting the images and signing the finding — more efficiently, more consistently, and more accessibly.
Every efficiency gain in reporting means less waiting time for a patient. Every structural improvement means a report reaches a patient in Gaza, Jamaica, or rural Canada with the same quality as one delivered at a Swiss university hospital.
A vote of confidence from Switzerland's innovation agency?
Innosuisse supports science-based innovation in Switzerland for the benefit of the economy and society. The approval of this grant reflects the agency's recognition of PARSOR's potential — clinically, technologically, and internationally.
"This grant is not just financial support — it is a signal that what we are building at RadiologyCheck has scientific and societal value. We are proud to carry the Innosuisse seal of endorsement as we build the next chapter of this platform."
— Dr. Ali Rahman, Founder & CEO, RadiologyCheck GmbH.
Learn more about PARSOR and RadiologyCheck's subspecialist second opinions — or request a radiology second opinion today: www.radiologycheck.com
